1. Advances in chronic limb-threatening ischemia.
- Author
-
Hammad, Tarek A and Shishehbor, Mehdi H
- Subjects
- *
PERIPHERAL vascular diseases , *ISCHEMIA , *TRANSLUMINAL angioplasty , *CARDIOVASCULAR system , *POPLITEAL artery , *GANGRENE - Abstract
Technology, peripheral artery disease (PAD), wound, revascularization, endovascular Depending on the case series, these range between 10% and 20% of all patients presenting with CLTI.[21] Deep vein arterialization is a novel therapy that uses the venous system to perfuse the foot by creating BTK artery-vein anastomosis using a stent graft. Keywords: technology; peripheral artery disease (PAD); wound; revascularization; endovascular EN technology peripheral artery disease (PAD) wound revascularization endovascular 126 130 5 04/12/21 20210401 NES 210401 If patients with ominous symptoms of either ischemic rest pain, tissue loss, or gangrene are left untreated, then one-quarter of these patients will lose their leg and another quarter will die within 6 months.[1] This is the natural history of chronic limb-threatening ischemia (CLTI); a condition that is more fatal than most known malignant neoplasms.[2] Accordingly, all societal guidelines give a class I recommendation for lower extremity revascularization for these patients.[1],[3],[4] This can be challenging and requires addressing severe multilevel disease, including heavily calcified infrapopliteal and inframalleolar arteries, which tend to be small with long and totally occlusive lesions. Endovascular revascularization algorithm for CLTI.CLTI, chronic limb-threatening ischemia; DCB, drug-coated balloon; DES, drug-eluting stent; PTA, percutaneous transluminal angioplasty; SFA, superficial femoral artery. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF